Sign inGet started

Verwijs Marinus

Insider CIK 1916553 · AVTE Senior Vice President, CMC

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
AVTE Aerovate Therapeutics, Inc M Exercise deriv2024-06-142024-06-1410,600— $068,800SEC↗
AVTE Aerovate Therapeutics, Inc M Exercise2024-06-142024-06-1410,600$14.59 $154.7K10,600SEC↗
AVTE Aerovate Therapeutics, Inc S Sale2024-06-142024-06-1410,600$25.00 $265.0K0SEC↗
AVTE Aerovate Therapeutics, Inc S Sale2024-05-022024-05-031,981$21.02 $41.6K0SEC↗
AVTE Aerovate Therapeutics, Inc M Exercise deriv2024-04-012024-04-035,300— $079,400SEC↗
AVTE Aerovate Therapeutics, Inc M Exercise2024-04-012024-04-035,300$14.59 $77.3K5,300SEC↗
AVTE Aerovate Therapeutics, Inc S Sale2024-04-012024-04-031,504$30.00 $45.1K0SEC↗
AVTE Aerovate Therapeutics, Inc S Sale2024-04-012024-04-033,796$28.87 $109.6K1,504SEC↗
AVTE Aerovate Therapeutics, Inc M Exercise deriv2024-03-192024-03-205,300— $084,700SEC↗
AVTE Aerovate Therapeutics, Inc S Sale2024-03-192024-03-202,764$26.46 $73.1K0SEC↗
AVTE Aerovate Therapeutics, Inc M Exercise2024-03-192024-03-205,300$14.59 $77.3K5,300SEC↗
AVTE Aerovate Therapeutics, Inc S Sale2024-03-192024-03-202,536$25.68 $65.1K2,764SEC↗
AVTE Aerovate Therapeutics, Inc A Award deriv2024-01-222024-01-2466,586— $066,586SEC↗
AVTE Aerovate Therapeutics, Inc S Sale2023-11-012023-11-03970$10.46 $10.1K0SEC↗
AVTE Aerovate Therapeutics, Inc S Sale2023-05-032023-05-05759$20.79 $15.8K0SEC↗
AVTE Aerovate Therapeutics, Inc A Award deriv2023-02-072023-02-0862,000— $062,000SEC↗
AVTE Aerovate Therapeutics, Inc S Sale2022-11-022022-11-031,130$18.89 $21.3K0SEC↗
AVTE Aerovate Therapeutics, Inc A Award deriv2022-03-212022-03-2390,000— $090,000SEC↗